Trials / Recruiting
RecruitingNCT05339477
The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study
The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study (ACTIVITY-SWEDEHEART)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- Sahlgrenska University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The association between objectively measured physical activity intensities (light, moderate and vigorous), sedentary time and clinical outcomes has not been clarified in patients after a myocardial infarction. The overall objective of the study is to explore associations between accelerometer measured physical activity and clinical outcomes after a myocardial infarction. Moreover, the association between changes in physical activity and outcomes will be assessed.
Detailed description
It is estimated to include 4000 patients with myocardial infarction during 2 years. Patients will wear the accelerometer for 7 days at follow-up visits (2 months and 1 year) after discharge. The investigators will examine the dose-response relations of several exposure variables from the accelerometer measurements with the outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Accelerometer measurement | Study personnel will initiate an accelerometer and inform the patient to wear the accelerometer with an elastic belt on their right hip during waking hours for seven consecutive days. Moreover, patients are instructed to register their wear time in an activity diary in paper form. In addition, patients will register their working hours, if relevant. After seven days, patients send back the accelerometer and diary in a pre-paid envelope. The same procedure is repeated at the second follow-up visit at 1 year. |
Timeline
- Start date
- 2022-04-26
- Primary completion
- 2026-04-26
- Completion
- 2029-04-26
- First posted
- 2022-04-21
- Last updated
- 2025-02-11
Locations
35 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05339477. Inclusion in this directory is not an endorsement.